Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke | Zendy

Ralph L. Sacco | Zendy; HansChristoph Diener | Zendy; Salim Yusuf | Zendy; Otto W. Witte | Zendy; Stephanie Ôunpuu | Zendy; William A Lawton | Zendy; Amy Yu | Zendy; Reneé H. Martin | Zendy; Gregory W. Albers | Zendy; Philip M. Bath | Zendy; Natan M. Bornstein | Zendy; Bernard P.L. Chan | Zendy; Christopher Chen | Zendy; Luı́s Cunha | Zendy; Björn Dahlöf | Zendy; Jacques De Keyser | Zendy; Geoffrey A. Donnan | Zendy; Conrado J. Estol | Zendy; Philip B. Gorelick | Zendy; Vivian Gu | Zendy; Karin Hermansson | Zendy; Lutz Hilbrich | Zendy; Markku Kaste | Zendy; Chuanzhen Lü | Zendy; Thomas Machnig | Zendy; Prem Pais | Zendy; Robin Roberts | Zendy; Veronika Skvortsova | Zendy; Philip Teal | Zendy; Danilo Toni | Zendy; Cam P. VanderMaelen | Zendy; Thor Voigt | Zendy; Michael A. Weber | Zendy; ByungWoo Yoon | Zendy; Francisco Macian-Montoro | Zendy; Group Prevention Regimen For Effectively Avoiding Second Strokes Study | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke

Author(s) -

Ralph L. Sacco,

HansChristoph Diener,

Salim Yusuf,

Otto W. Witte,

Stephanie Ôunpuu,

William A Lawton,

Amy Yu,

Reneé H. Martin,

Gregory W. Albers,

Philip M. Bath,

Natan M. Bornstein,

Bernard P.L. Chan,

Christopher Chen,

Luı́s Cunha,

Björn Dahlöf,

Jacques De Keyser,

Geoffrey A. Donnan,

Conrado J. Estol,

Philip B. Gorelick,

Vivian Gu,

Karin Hermansson,

Lutz Hilbrich,

Markku Kaste,

Chuanzhen Lü,

Thomas Machnig,

Prem Pais,

Robin Roberts,

Veronika Skvortsova,

Philip Teal,

Danilo Toni,

Cam P. VanderMaelen,

Thor Voigt,

Michael A. Weber,

ByungWoo Yoon,

Francisco Macian-Montoro,

Group Prevention Regimen For Effectively Avoiding Second Strokes Study

Publication year - 2008

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa0805002

Subject(s) - dipyridamole , clopidogrel , aspirin , medicine , stroke (engine) , ticlopidine , cardiology , anesthesia , physics , thermodynamics

Recurrent stroke is a frequent, disabling event after ischemic stroke. This study compared the efficacy and safety of two antiplatelet regimens--aspirin plus extended-release dipyridamole (ASA-ERDP) versus clopidogrel.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore